This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1981 Nov;41(11 Pt 1):4316-23.

Drug-binding macromolecular lipids from L1210 leukemia tumors

R F Taylor, L A Teague, D W Yesair

PMID: 7306962

Drug-binding macromolecular lipids from L1210 leukemia tumors

R F Taylor et al. Cancer Res. 1981 Nov.

. 1981 Nov;41(11 Pt 1):4316-23.

Authors

R F Taylor, L A Teague, D W Yesair

PMID: 7306962

No abstract available

PubMed Disclaimer

Similar articles

Binding of the Cain quinolinium, NSC 113089, to rat tissue lipid extracts.
Yesair DW, Callahan M, McComish MF, Taylor RF. Yesair DW, et al. Cancer Biochem Biophys. 1979;3(4):163-8. Cancer Biochem Biophys. 1979. PMID: 552904
In vitro binding of 67Ga to L1210 cells.
Glickson JD, Ryel RB, Bordenca MM, Kim KH, Gams RA. Glickson JD, et al. Cancer Res. 1973 Nov;33(11):2706-13. Cancer Res. 1973. PMID: 4795900 No abstract available.
Pharmacological implications of the interaction of heavy metals with novel macromolecular lipids.
Yesair DW, Taylor RF. Yesair DW, et al. Drug Metab Rev. 1982;13(3):517-33. doi: 10.3109/03602538209029993. Drug Metab Rev. 1982. PMID: 7105973 No abstract available.
The comparative effects of 5-azacytidine and dihydro-5-azacytidine on 4 S and 5 S nuclear RNA.
Glazer RI, Hartman KD. Glazer RI, et al. Mol Pharmacol. 1980 Mar;17(2):250-5. Mol Pharmacol. 1980. PMID: 6156396 No abstract available.
Cain's quinolinium (NSC 176319): protection of murine L1210 leukemia cells and bone marrow progenitor cells against mechlorethamine cytotoxicity and its application to combination chemotherapy.
Naujokaitis SA. Naujokaitis SA. Res Commun Chem Pathol Pharmacol. 1981 Oct;34(1):97-104. Res Commun Chem Pathol Pharmacol. 1981. PMID: 7313308

See all similar articles

Cited by

Membrane lipid alteration: effect on cellular uptake of mitoxantrone.
Burns CP, Haugstad BN, Mossman CJ, North JA, Ingraham LM. Burns CP, et al. Lipids. 1988 May;23(5):393-7. doi: 10.1007/BF02535508. Lipids. 1988. PMID: 3412115
5'-Nucleotidase activity and arachidonate metabolism in doxorubicin sensitive and resistant P388 cells.
Ramu A, Glaubiger D, Soprey P, Reaman GH, Feuerstein N. Ramu A, et al. Br J Cancer. 1984 Apr;49(4):447-51. doi: 10.1038/bjc.1984.71. Br J Cancer. 1984. PMID: 6324840 Free PMC article.
Resistance to cytostatic drugs at the cellular level.
Vendrik CP, Bergers JJ, De Jong WH, Steerenberg PA. Vendrik CP, et al. Cancer Chemother Pharmacol. 1992;29(6):413-29. doi: 10.1007/BF00684841. Cancer Chemother Pharmacol. 1992. PMID: 1568284 Review. No abstract available.
Terephthalamidine: past and future.
Fisherman JS, Cline EM, Plowman J, Quinn FR, Hawkins MJ. Fisherman JS, et al. Invest New Drugs. 1991 Nov;9(4):295-303. doi: 10.1007/BF00183569. Invest New Drugs. 1991. PMID: 1804802 Review.
Lack of involvement of reactive oxygen in the cytotoxicity of mitoxantrone, CI941 and ametantrone in MCF-7 cells: comparison with doxorubicin.
Fisher GR, Patterson LH. Fisher GR, et al. Cancer Chemother Pharmacol. 1992;30(6):451-8. doi: 10.1007/BF00685596. Cancer Chemother Pharmacol. 1992. PMID: 1394801

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

N01-CM87163/CM/NCI NIH HHS/United States